Biomedical subjects

M J Strazzari

Publications and source records attributed to M J Strazzari.

2 recordsLinked to original sources

PubMed1996

Vitamin A-deficient rats have only mild changes in jejunal structure and function.

This study investigated the effect of clinical and subclinical vitamin A deficiency on intestinal structure and function in rats. Weanling male rats fed a vitamin A-deficient diet (VA-) for 40-42 or 60-63 d were compared with rats either pair-fed (PF) or with free access to the same diet supplemented with vitamin A (VA+). A reference (REF) group was fed a standard rat diet. Weight began to plateau in VA- rats after 42 d, becoming significantly different from PF rats at 60-63 d (P < 0.02). Diarrhea did not develop in any study group. VA- rats had clinical signs of vitamin A deficiency in the 60-63 d study, but not in the 40-42 d study. However, serum and liver retinol concentrations were negligible in all VA- rats. VA- rats in the 60-63 d study had significantly reduced villus height (P < 0.02), and sucrase and maltase activities (P < 0.02) compared with PF rats. There were no differences between VA- and PF rats in mucosal wet weights, protein and DNA concentrations, thymidine kinase activity and glucose transport. No differences were detected in the 40-42 d study for any variable measured. Because clinical vitamin A deficiency in rats causes only mild changes in intestinal structure and function, it is unlikely that these alterations alone are responsible for the interactions observed in epidemiological studies between vitamin A deficiency and diarrheal disease.

Animals↗

PubMed1993

Evidence that the Ca2+ inflow pathway in hepatocytes stimulated by thapsigargin is similar to that activated by vasopressin.

Experiments were conducted to characterize the thapsigargin-stimulated plasma membrane Ca2+ inflow pathway in hepatocytes. Ca2+ inflow was estimated by measurement of the initial rate of activation of glycogen phosphorylase a following the addition of Ca2+ to cells previously incubated in the absence of added Ca2+. Pretreatment of hepatocytes with thapsigargin caused a substantial stimulation of the rate of Ca2+ activation of glycogen phosphorylase a. This was interpreted to reflect a stimulation of plasma membrane Ca2+ inflow. The effect of thapsigargin on plasma membrane Ca2+ inflow was approximately 65% of the magnitude of the effect caused by vasopressin. When thapsigargin and vasopressin were combined as a stimulus, the degree of stimulation was similar to that caused by vasopressin alone. The thapsigargin-induced stimulation of the rate of Ca2+ activation of glycogen phosphorylase a was inhibited in a concentration-dependent manner by both Zn2+ and 1-(beta-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl)-1H-imidazole hydrochloride (SK&F 96365). The concentration of each agent required for half-maximal inhibition was approximately 20 microM. It is concluded from: (i) the apparent lack of additivity in the responses of thapsigargin and vasopressin, and (ii) the sensitivity to inhibitors, that the Ca2+ inflow pathway in hepatocytes stimulated by thapsigargin is likely to be similar to that which is activated by vasopressin.

Animals↗